Related Experiment Video
Updated: Feb 14, 2026
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.1K
Tumor target amplification: Implications for nano drug delivery systems
Khaled Seidi1, Heidi A Neubauer2, Richard Moriggl3
1Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Summary
Target amplification strategies enhance cancer cell targeting by overcoming tumor heterogeneity. Novel approaches like self-amplifying systems and dual targeting improve therapeutic efficacy and reduce drug resistance.
Area of Science:
- Oncology
- Biotechnology
- Nanomedicine
Background:
- Tumor cells exhibit unique surface markers for targeted therapy.
- Tumor heterogeneity limits the effectiveness of current ligand-directed cancer cell targeting.
- Untargeted cancer cells can lead to drug resistance and relapse.
Purpose of the Study:
- To review limitations of current ligand-directed targeting strategies.
- To provide an overview of tumor target amplification strategies.
- To discuss the therapeutic and diagnostic potential of these novel approaches.
Main Methods:
- Review of existing literature on tumor target amplification.
- Analysis of self-amplifying systems, dual targeting, artificial markers, and peptide modification.
- Discussion of nanodelivery systems for enhanced targeting.
Main Results:
- Tumor heterogeneity poses a significant challenge for effective cancer cell targeting.
- Target amplification strategies offer potential solutions to improve treatment outcomes.
- Various methods, including self-amplifying systems and dual targeting, are being explored.
Conclusions:
- Target amplification is crucial for effective ligand-directed cancer therapy.
- Novel strategies can overcome limitations of current targeting methods.
- These approaches hold promise for improved cancer monitoring and treatment.
Keywords:
Ligand-directed targetingnano drug delivery systemstumor heterogeneity, tumor target amplificationMore Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
16
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
16
01:18Transdermal Drug Delivery Systems
21
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
21
01:23Ophthalmic Drug Delivery Systems
21
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
21
01:21Intrauterine Drug Delivery Systems
17
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
17
01:27Drug Delivery Systems: Different Types
16
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
16